Analyst Ratings for Nektar Therapeutics (NKTR) [Neutrals]
NKTR Rating Summary
NKTR Price Target Summary
- Highest: $5.00 (Mizuho)
- Lowest: $1.00 (Jefferies)
- Average: $3.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$3.00 (+120.6%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
Avg. $ Target:
$3.00 (+120.6%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/10/2023 | Jefferies » Updated 3/5/2024 |
Roger Song | Upgrade | Hold (Underperform) |
1.00 (0.50) |
0.77 (1.36) |
76.62% | Details |
| 3/15/2022 | Mizuho » Updated 11/8/2023 |
Mara Goldstein | Downgrade | Neutral (Buy) |
5.00 (6.00) |
10.63 (1.36) |
-87.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
